On behalf of NCI’s Epidemiology and Genomics Research Program (EGRP), it is my pleasure to inform you that your manuscript, Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa, has been included in EGRP’s Research Highlights for 2022. In October 2022, EGRP asked NCI grantees with projects supported by current or recently closed grants (i.e., grants that ended in 2021 or 2022) that are or were managed by EGRP to nominate one publication from 2022 that exemplified the research from the grant.
top of page
Search
Recent Posts
See AllExecutive summary Prostate cancer is the most common cancer in men in 112 countries, and accounts for 15% of cancers. In this Commission, we report projections of prostate cancer cases in 2040 on the
Abstract: This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 2
bottom of page